GeneDx Holdings Corp.
WGSdata completeness 100%7 fiscal years on fileGeneDx Holdings Corp. earns about -480% on invested capital, and has bought back 73% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $212.2M1 | $234.7M2 | $202.6M3 | $305.5M3 | $427.5M3 |
| Net income | −$245.4M4 | −$549M5 | −$175.8M6 | −$52.3M6 | −$21M6 |
| Operating cash flow | −$190.4M7 | −$319.2M8 | −$180.1M9 | −$28.5M9 | $33.3M9 |
| Capital expenditure | $9.4M10 | $7.16M11 | $5.25M12 | $5.49M12 | $19M12 |
| Free cash flow (derived) | −$199.8M7 | −$326.3M8 | −$185.4M9 | −$34M9 | $14.3M9 |
| Total debt | $22M13 | $22M14 | $109.4M15 | $108.9M16 | $107.3M16 |
| Cash & equivalents | $400.6M17 | $123.9M18 | $99.7M19 | $85.2M20 | $105M20 |
| Diluted shares | 108.1M | 10.2M | 24.3M | 26.9M | 28.6M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $107.6 of net worth that earned you −$7.34 and generated $4.98 of cash last year, against $37.45 of debt.
It earned an average -480% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 73% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 388% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001818331-23-000024 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001818331-24-000008 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001818331-26-000015 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001818331-23-000024 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001818331-24-000008 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001818331-26-000015 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001818331-23-000024 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001818331-24-000008 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001818331-26-000015 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001818331-23-000024 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001818331-24-000008 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001818331-26-000015 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001818331-23-000024 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0001818331-24-000008 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0001818331-25-000021 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0001818331-26-000015 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001818331-23-000024 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001818331-24-000008 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001818331-25-000021 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001818331-26-000015 (CashAndCashEquivalentsAtCarryingValue)